European Archives - Page 858 of 1365 - European Medical Journal

Stem Cell Therapies: A Review of Current Therapeutic Approach for Inflammation-Associated Sigmoid Colon Diseases

Chronic inflammation is the single major contributor to the pathogenesis of sigmoid colon inflammatory diseases such as segmental colitis associated disease and inflammatory bowel disease (IBD)

That Gut Feeling: The Role of Inflammatory Cytokines in Depression Among Patients with Inflammatory Bowel Disease

There is mounting evidence of an associative link between inflammatory bowel disease (IBD) and clinical depression…

An Overview of Novel and Emerging Therapies for Inflammatory Bowel Disease

Inflammatory bowel disease, consisting of Crohn’s disease and ulcerative colitis, causes chronic gastrointestinal symptoms and can lead to morbidity and mortality if uncontrolled or untreated.

Pneumoperitoneum, Pneumothorax, and Pneumoretroperitoneum Post Colonoscopy: A Case report and Review of Literature

Colonic perforation post colonoscopy is rarely seen; however, when coupled with massive pneumoperitoneum in haemodynamically stable patients,

Achalasia Cardia: A Comprehensive Review

Achalasia cardia is the best characterised oesophageal motility disorder. It is characterised by progressive ganglion cell degeneration in the oesophageal myenteric plexus, which results in impaired lower oesophageal sphincter (LES) relaxation upon swallowing and aperistalsis in the distal smooth muscle segment of the oesophagus.

SARS-CoV-2-Associated Nephropathy: Direct Renal Infection and Damage

Acute kidney injury is a frequent complication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), principally because of hypotension and…

EMJ Podcast: Paediatric Hepatology

This week, Jonathan is joined by Deirdre Kelly, Paediatric Hepatologist and Chair of the ESPGHAN Public Affairs Committee.

Lower eGFR Leads to More Major Surgeries: Study with 1,455,512 Patients

MAJOR surgery is more likely for individuals with kidney disease compared with people who have normal kidney function.

Sotagliflozin Associated with Reduced Risk of Cardiovascular Events

SOTAGLIFLOZIN is a sodium–glucose cotransporter 2 (SGLT2) inhibitor that may reduce the risk of urgent medical care for heart failure, hospitalisation…

Are We Virtually There Yet? Part 2 of 2

This two-part webinar features experts who have been on the leading edge of technology in medicine and share their thoughts on where telemedicine was, where it is now and where it is going.